(Q58177753)

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Cell cycle regulatory proteins in podocyte health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Pathogenesis of nonimmune glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Alpha-crystallin can function as a molecular chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Apoptosis in podocytes induced by TGF-beta and Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Direct effects of dexamethasone on human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

The balance of autocrine VEGF-A and VEGF-C determines podocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Expression of functional CCR and CXCR chemokine receptors in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Coronary calcium score in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Essential role of calcineurin in response to endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Calcineurin: a central controller of signalling in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Proteinuria: an enzymatic disease of the podocyte?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Association of immunophilins with mammalian TRPC channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Slit diaphragms contain tight junction proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Cyclosporin therapy in patients with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Sirolimus interacts with pathways essential for podocyte integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Clinical predictors of proteinuria after conversion to sirolimus in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ617